NATIONAL BANK OF CANADA /FI/ - INOVIO PHARMACEUTICALS INC ownership

INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 187 filers reported holding INOVIO PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 1.11 and the average weighting 0.0%.

Quarter-by-quarter ownership
NATIONAL BANK OF CANADA /FI/ ownership history of INOVIO PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$254
-14.5%
6600.0%0.00%
Q2 2023$297
-80.9%
660
-65.3%
0.00%
Q1 2023$1,558
-47.1%
1,9000.0%0.00%
Q4 2022$2,945
-1.8%
1,9000.0%0.00%
Q3 2022$3,0000.0%1,9000.0%0.00%
Q2 2022$3,000
-57.1%
1,9000.0%0.00%
Q1 2022$7,000
-22.2%
1,9000.0%0.00%
Q4 2021$9,0001,9000.00%
Other shareholders
INOVIO PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Defender Capital, LLC. 648,800$1,920,0001.55%
Round Table Services, LLC 339,391$998,0000.31%
ARK Investment Management 3,955,017$11,628,0000.29%
Nikko Asset Management Americas, Inc. 4,884,100$14,359,0000.28%
WASATCH ADVISORS LP 6,735,726$19,803,0000.19%
Cedar Brook Financial Partners, LLC 41,500$122,0000.06%
Unified Trust Company, N.A. 15,716$46,0000.03%
Bay Colony Advisory Group, Inc d/b/a Bay Colony Advisors 13,500$40,0000.03%
STONERIDGE INVESTMENT PARTNERS LLC 16,914$50,0000.02%
Sumitomo Mitsui Trust Holdings, Inc. 4,884,100$14,359,0000.01%
View complete list of INOVIO PHARMACEUTICALS INC shareholders